Inactive Instrument

News RXi Pharmaceuticals Corp Nasdaq

Equities

US74979C5013

Summary

Unlock all the news: Be the first to know and act before the market!

Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging	18/06	NE
Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee of Phase 1b Clinical Study of Phio's Lead Compound PH-762	29/05	AQ
Phio Pharmaceuticals Corp. Announces Positive Recommendation from Safety Monitoring Committee of Phase 1b Clinical Study of Phio's Lead Compound PH-762	29/05	CI
Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762	28/05	NE
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO)	24/05	NE
Phio Pharmaceuticals Files $100 Million Mixed Shelf	21/05	MT
Phio Pharmaceuticals Secures New Investor	17/05	AQ
Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)	16/05	AQ
Phio Pharmaceuticals Doses 1st Group in Skin Cancer Treatment Study	15/05	MT
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study	15/05	AQ
Phio Pharmaceuticals Corp Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study	15/05	CI
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update	10/05	GL
Phio Pharmaceuticals Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05	CI
Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)	30/04	AQ
Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells	22/04	AQ
Phio Pharmaceuticals Corp. Presents New Data About Its Lead Clinical Product Candidate, PH-762	22/04	CI
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)	16/04	AQ
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology	16/04	CI
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)	11/04	AQ
National Spotlight Features Phio’s Innovative RNAi Technology Platform	03/04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News RXi Pharmaceuticals Corp Nasdaq

Equities

US74979C5013

Summary

Filters